Arkolith/Insider Trading/VRCA/Form 4

Goldenberg Gary

Chief Medical OfficerVerrica Pharmaceuticals Inc. (VRCA) · full profile →Form 4 · filed Aug 28, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$35K
Net Open-Market Flow
-$35K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 27, 2024Sell(S)4K$2.46$9K94K
Aug 26, 2024Sell(S)10K$2.66$26K98K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-022426) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML